Cynata Therapeutics secures $8.1m funding after promising results from diabetic foot ulcers trial

Cynata Therapeutics Limited, a clinical-stage biotechnology company listed on the Australian Securities Exchange (ASX: CYP), has raised A$8.1 million through an institutional placement. The funding ... Read More